Nurşah Eker, Burcu Tufan Taş, Ömer Doğru, Emel Şenay, Ayşe Gülnur Tokuç, & Ahmet Koç. (2022). Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation. Galenos Yayinevi.
Chicago Style (17th ed.) CitationNurşah Eker, Burcu Tufan Taş, Ömer Doğru, Emel Şenay, Ayşe Gülnur Tokuç, and Ahmet Koç. Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child After Autologous Stem Cell Transplantation. Galenos Yayinevi, 2022.
MLA (9th ed.) CitationNurşah Eker, et al. Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child After Autologous Stem Cell Transplantation. Galenos Yayinevi, 2022.
Warning: These citations may not always be 100% accurate.